How does the Medibank (ASX:MPL) earnings result compare to NIB?

It's been a tale of two health insurance shares on the ASX this week

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) earnings result was one to watch this week. The Aussie private health insurer released its full-year results for the year ended 30 June 2021 (FY21) and had an instant share price impact.

The Medibank share price jumped 2% higher on Wednesday morning following the release before closing the day 0.6% higher at $3.57 per share.

As one of the biggest weeks of the August earnings season comes to a close, let's compare the Medibank result against that of rival insurer, NIB Holdings Limited (ASX: NHF).

How does the Medibank earnings result compare to NIB?

In case you missed it, some of the big takeaways from Medibank's earnings result on Wednesday were:

  • Revenue up 1.99% on the prior corresponding period (pcp) to $6.9 billion
  • Net profit after tax (NPAT) up 39.8% on pcp to $441 million
  • Earnings per share (EPS) up 39.8% on pcp to 16 cents
  • Final dividend of 6.9 cents per share, making for a 5.8% increase in the full-year dividend to 12.7 cents per share

It's worth noting the surge in profits was helped by a 4,900% increase in net investment income throughout the year.

In contrast, the NIB share price sank 6.3% lower on Monday following its half-year earnings update. The Aussie private health insurer reported that revenue was down 2.9% on pcp to $2.6 billion with expense claims up 2.5% on pcp to $2 billion.

NPAT came in 84.5% higher on pcp at $160.5 million, while NIB announced a 14 cents per share final dividend, fully franked.

There's no doubt that the COVID-19 pandemic continues to weigh on earnings across the ASX but particularly for the Aussie health insurers.

The Medibank earnings result sent the company's shares soaring while the same can't be said for NIB. NIB reported significantly weakened international inbound and travel earnings as a result of the COVID-19 pandemic.

The group has also put aside $34 million in provisions to catch up on deferred claims in relation to COVID-19.

The NIB share price has climbed 10% higher in 2021 while Medibank shares are up 16.1% year to date. While shares in both insurers have seen double-digit gains, it does mean that Medibank is outperforming the S&P/ASX 200 Index (ASX: XJO) while NIB is not.

Should you invest $1,000 in S&P/ASX 200 right now?

Before you buy S&P/ASX 200 shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and S&P/ASX 200 wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Financial Shares

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Financial Shares

HMC Capital announces plans for new equity fund: Should I invest?

Let's see if some big news makes it a good time to buy this stock.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Share Market News

ASX 200 financial shares lead the market amid Federal Budget and election call

ASX financial shares led the 11 market sectors last week with a 2.55% gain.

Read more »

Man smiling at a laptop because of a rising share price.
Dividend Investing

Why this sold-off ASX All Ords dividend stock is 'well placed to generate long-term shareholder value'

A leading expert sees long-term value in this beaten-down ASX All Ords dividend stock.

Read more »

Woman insurance agent fills out insurance form for car damage after traffic accident.
Financial Shares

Down 10% this year, is it time to buy IAG shares in the dip?

Is it time to jump in or jump ship on this ASX 200 insurance company?

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Financial Shares

Down 7% in 2025, should I buy Macquarie shares now?

Here’s what you need to know.

Read more »

A man and woman watch their device screens, making investing decisions at home.
Financial Shares

Down 20% this year, are AMP shares ripe for a rebound?

After a difficult start to 2025, can the financial stock bounce back?

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Financial Shares

Trading near a 1 year low, is it time to buy Macquarie shares?

Is now a good time to invest? Let's see what one leading broker is saying.

Read more »

Frustrated and shocked business woman reading bad news online from phone.
Financial Shares

Guess which ASX 200 share is crashing 29% because of CBA

Helia Group Ltd (ASX: HLI) shares are having a day to forget on Monday. In early trade, the ASX 200…

Read more »